142 related articles for article (PubMed ID: 20567964)
1. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.
Gonnelli S; Caffarelli C; Maggi S; Guglielmi G; Siviero P; Rossi S; Crepaldi G; Nuti R;
Calcif Tissue Int; 2010 Aug; 87(2):137-43. PubMed ID: 20567964
[TBL] [Abstract][Full Text] [Related]
2. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study.
Nuti R; Siviero P; Maggi S; Guglielmi G; Caffarelli C; Crepaldi G; Gonnelli S
Osteoporos Int; 2009 Jun; 20(6):989-98. PubMed ID: 18931817
[TBL] [Abstract][Full Text] [Related]
3. Inhaled glucocorticoids are associated with vertebral fractures in COPD patients.
Gonçalves PA; Dos Santos Neves R; Neto LV; Madeira M; Guimarães FS; Mendonça LMC; Lopes AJ; Farias MLF
J Bone Miner Metab; 2018 Jul; 36(4):454-461. PubMed ID: 28766137
[TBL] [Abstract][Full Text] [Related]
4. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study.
Maggi S; Siviero P; Gonnelli S; Schiraldi C; Malavolta N; Nuti R; Crepaldi G;
J Clin Densitom; 2009; 12(3):345-52. PubMed ID: 19647671
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
7. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
Kumagai S; Kawano S; Atsumi T; Inokuma S; Okada Y; Kanai Y; Kaburaki J; Kameda H; Suwa A; Hagiyama H; Hirohata S; Makino H; Hashimoto H
J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
[TBL] [Abstract][Full Text] [Related]
8. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
Korsgaard J; Ledet M
Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
[TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
Pujades-Rodríguez M; Smith CJ; Hubbard RB
QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
[TBL] [Abstract][Full Text] [Related]
10. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.
Jørgensen NR; Schwarz P; Holme I; Henriksen BM; Petersen LJ; Backer V
Respir Med; 2007 Jan; 101(1):177-85. PubMed ID: 16677808
[TBL] [Abstract][Full Text] [Related]
12. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
13. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD;
J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
[TBL] [Abstract][Full Text] [Related]
14. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.
McEvoy CE; Ensrud KE; Bender E; Genant HK; Yu W; Griffith JM; Niewoehner DE
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):704-9. PubMed ID: 9517579
[TBL] [Abstract][Full Text] [Related]
15. [Management of osteoporosis in patients with inhaled glucocorticoids].
Wada S; Kamiya S; Fukawa T
Clin Calcium; 2006 Nov; 16(11):1871-77. PubMed ID: 17079855
[TBL] [Abstract][Full Text] [Related]
16. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
Kiri VA; Bettoncelli G; Testi R; Viegi G
Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada.
Papaioannou A; Parkinson W; Ferko N; Probyn L; Ioannidis G; Jurriaans E; Cox G; Cook RJ; Kumbhare D; Adachi JD
Osteoporos Int; 2003 Nov; 14(11):913-7. PubMed ID: 14551675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
